shortage of tirzepatide FDA Resolves Shortage: Impact on Supply Chain Addressing the Weight Loss Injectable

A look at the fast-growing compounding pharmacy in Houston Eli Lilly argued in its lawsuit that Empower violated federal trademark laws and state unfair competition laws by selling "untested and unapproved" versions of their tirzepatide products, Mounjaro and Zepbound, which the company said it spent billions of dollars to develop

Already its a red flag to see them being sold online because that is not the authorised channel, says Mokgadi Fafudi, SAHPRAs regulatory compliance manager

Patent databases show that the key substance patents covering the drugs molecular structure extend into 2036 , with additional formulation and delivery-related patents that may extend protections to 2039

Its active ingredient, semaglutide, works by mimicking a hormone that helps regulate blood sugar levels

Ghost's strategic V2 included PureWay-C (vitamin C) to synergize with Setria, and pine bark extract (95% proanthocyanidins) for more blood flow support